Individual Placement and Support for Opioid Abuse

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa, AL
Opioid Abuse+2 More
Individual Placement and Support (IPS) - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to help Veterans who have opioid use problems with gaining and maintaining meaningful employment. The investigators also want to know employment helps with other aspects of the Veteran's life including starting and staying on necessary medications, mental health needs, and feeling a part of society.

Eligible Conditions

  • Opioid Abuse
  • Veterans With Opioid Use Disorder

Treatment Effectiveness

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: 15 months

15 months
Anxiety
Depression
Quality of Life
Resilience
number of weeks worked
social support
15-months
suicide risk

Trial Safety

Trial Design

2 Treatment Groups

Treatment As Usual Vocational Rehabilitation (TAU-VR)
1 of 2
Individual Placement and Support
1 of 2
Active Control
Experimental Treatment

120 Total Participants · 2 Treatment Groups

Primary Treatment: Individual Placement and Support · No Placebo Group · N/A

Individual Placement and Support
Other
Experimental Group · 1 Intervention: Individual Placement and Support (IPS) · Intervention Types: Other
Treatment As Usual Vocational Rehabilitation (TAU-VR)
Other
ActiveComparator Group · 1 Intervention: Treatment As Usual Vocational Rehabilitation (TAU-VR) · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 15 months
Closest Location: Tuscaloosa VA Medical Center, Tuscaloosa, AL · Tuscaloosa, AL
2005First Recorded Clinical Trial
0 TrialsResearching Opioid Abuse
9 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are currently unemployed or underemployed.
You are willing and able to give informed consent.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.